AEON Biopharma, Inc.
AEON
$0.69
-$0.0043-0.62%
AMEX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 12.06M | 12.12M | 13.64M | 15.70M | 18.97M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 17.95M | 21.39M | 27.82M | 33.70M | 43.96M |
Operating Income | -17.95M | -21.39M | -27.82M | -33.70M | -43.96M |
Income Before Tax | -1.64M | 169.12M | 42.01M | 13.68M | -305.52M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -1.64 | 169.12 | 42.01 | 13.68 | -305.52 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -1.64M | 169.12M | 42.01M | 13.68M | -305.52M |
EBIT | -17.95M | -21.39M | -27.82M | -33.70M | -43.96M |
EBITDA | -17.87M | -21.30M | -27.73M | -33.60M | -43.86M |
EPS Basic | -5.81 | 298.79 | 68.64 | 14.04 | -362.77 |
Normalized Basic EPS | -9.37 | -7.85 | -74.34 | -72.69 | -97.67 |
EPS Diluted | -6.37 | 298.23 | 68.07 | 13.76 | -362.77 |
Normalized Diluted EPS | -9.36 | -7.84 | -74.33 | -72.69 | -97.67 |
Average Basic Shares Outstanding | 16.16M | 5.63M | 2.16M | 2.12M | 2.41M |
Average Diluted Shares Outstanding | 16.16M | 5.63M | 2.16M | 2.12M | 2.41M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |